NCT04417660 2026-04-07
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
Clinical Trials
14 trialsNCT05104736 2026-04-07
PT-112 in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07463313 2026-03-11
6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2/3 Not yet recruiting
NCT07383142 2026-02-06
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)
Shanghai Zhongshan Hospital
Phase NA Not yet recruiting
NCT06311955 2025-06-13
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
Shanghai Proton and Heavy Ion Center
Phase 2 Recruiting
NCT06311968 2025-06-13
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Shanghai Proton and Heavy Ion Center
Phase 2 Recruiting
NCT06692062 2024-11-18
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Xiangya Hospital of Central South University
Phase NA Recruiting
NCT06654830 2024-10-30
RATT Vs. VATT for Early-stage TETs
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT06200233 2024-04-09
Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Samsung Medical Center
Phase 2 Not yet recruiting
NCT04667793 2023-04-04
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Unknown
NCT05446935 2022-09-19
CHOICE
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT03858582 2021-03-22
neoadjuvant_thymic Epithelial Tumor
Samsung Medical Center
Phase 2 Unknown
NCT04517539 2020-08-18
Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
Shanghai Cancer Hospital, China
Phase 2 Unknown
NCT00818090 2013-04-12
Paclitaxel and Cisplatin for Thymic Neoplasm
Korean Cancer Study Group
Phase 2 Terminated